Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Vinorelbine, and Liposomal Doxorubicin in Relapsed/Refractory Hodgkin's Disease
NCT00006029Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 2000
- Primary completion
- Feb 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine, doxorubicin, vinorelbine in Hodgkin lymphoma (HL), sponsored by Cancer and Leukemia Group B. Started Jul 2000; status: completed.
02
Drugs
gemcitabinedoxorubicinvinorelbine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00006029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006029.